Navigation Links
Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious 'Outstanding Contribution' Award
Date:3/3/2011

WASHINGTON, March 3, 2011 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers, has honored Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt with the industry's prestigious "Outstanding Contribution" Award.  

(Photo: http://photos.prnewswire.com/prnh/20110303/DC58687)

The award was presented at GPhA's Annual Meeting in Orlando, Florida.  PCMA represents the nation's PBMs which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

"I'm honored to receive this award and proud to stand with GPhA, employers, and consumer groups in the fight for affordable prescription drugs," said PCMA President and CEO Mark Merritt.  

Proven PBM tools and techniques – including increasing the use of generic medications – has helped result in drug spending during the 2007-2009 period growing at its slowest annual rates in more than 40 years.   Research released by the Congressional Budget Office (CBO) found that the use of generic medications rather than brand-name medications in Medicare Part D saved beneficiaries and the program about $33 billion in 2007 with an additional $14 billion in savings expected as first-time generics enter the market through 2012. Over the past decade, generic medications have helped save the United States health care system $824 billion.  

The Generic Pharmaceutical Association (GPhA) represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 75 percent of the prescriptions dispensed in the U.S. but consume just 22 percent of the total drug spending.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Receives Approval for Generic Version of Neurontin® Capsules
2. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
3. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
4. PCMA: Generics, Mail-Service Pharmacy Recognized as Ways to Reduce Costs for TRICARE Program
5. Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
6. Mylan Launches First Generic Version of Vfend® Tablets
7. PCMA: Some Drugmakers Lobbying to Limit E-Prescribing of Generics, Drug Safety Checks
8. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
9. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
10. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
11. Mylans Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based ... In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... company had 800 customers and 2,250 RCEs at the time of acquisition. In ...
(Date:2/27/2017)... , ... February 27, 2017 , ... New Jersey ranks ... among all types and genders. And the need for advanced services is growing. ... its top-rated cancer care program, in collaboration with their non-profit partners in their fight ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... NuevaCare, a ... as diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important ... Bay Area consumers look for home care close to home, and by having city-specific ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ODH, Inc.™ ... Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director ... to use behavioral health analytics to improve Medicaid population health management. , ODH will ...
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
Breaking Medicine News(10 mins):